Wingderm® Presents at the 2025 AAD Annual Meeting, Strengthening Its Presence in the North American Market
BEIJING, March 11, 2025 /PRNewswire/ -- Wingderm® once again participated in the 2025 AAD Annual Meeting, which was held in Orlando, Florida, from March 7 to 9. The American Academy of Dermatology is the largest, most influential, and most representative dermatologic association. During the event, attendees had the opportunity to discover the latest technological innovations from Wingderm® and their applications....
Gan & Lee Pharmaceuticals Announced First Participant Dosed in the US Phase 2 Clinical Study of Bofanglutide (GZR18) Injection for Overweight or Obesity
BEIJING and BRIDGEWATER, N.J., March 10, 2025 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced that the first participant has been successfully dosed in a Phase 2 clinical trial of bofanglutide (research code: GZR18) injection, a bi-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) independently developed by Gan & Lee, in the US participants with...
TCI Biotech Announces Strong 2024 Financial Performance, Sets Sights on Global Growth in 2025
TAIPEI, March 10, 2025 /PRNewswire/ -- TCI Biotech (TCI Co., Ltd.) (TWSE: 8436), a leading CDMO+ innovator in health food and skincare biotechnology, has released its consolidated financial results for the fiscal year ending December 31, 2024. The company reported steady revenue performance, strong profitability, and continued investment in innovation to drive future growth. Executive Commentary "Our 2024 financial...
Sunway Medical Centre named top Malaysian Hospital in Newsweek’s World’s Best Hospitals ranking
SUBANG JAYA, Malaysia, March 10, 2025 /PRNewswire/ -- Sunway Medical Centre, Sunway City (SMC) has yet again ranked in the top 250 hospitals globally in the latest Newsweek's World's Best Hospitals 2025 rankings. (from left) Dato Lau Beng Long, President, Sunway Healthcare Group (SHG); Dr Khoo Chow Huat, Managing Director, Hospital & Healthcare Operations, SHG;...
World’s First Large-Scale, Multicenter Prospective Study in Single-Reading Mammography Confirms Lunit AI Boosts Cancer Detection
Prospective study finds Lunit AI increases cancer detection by 13.8% in single-reader settings without raising recall rates, presenting a game-changing tool for countries relying on single-reader mammography screening SEOUL, South Korea, March 10, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the publication...
RITFIT Calls for Real Strength to Accelerate Action on International Women’s Day
CHINO HILLS, Calif., March 10, 2025 /PRNewswire/ -- This March, RITFIT has launched a series of events under the theme "Empowering Women: Health and Strength in the Home Gym," in alignment with this year's International Women's Day theme, "Accelerate Action." The initiative encourages women to prioritize their health and embrace strength, both physically and mentally. With participation from thousands...
Gleneagles Hospital Hong Kong pioneers transformative Histotripsy treatment for liver cancer in private sector in Asia
HONG KONG, March 10, 2025 /PRNewswire/ -- Gleneagles Hospital Hong Kong (Gleneagles) is excited to be the first private hospital in Asia to offer Histotripsy treatment, the transformative and non-invasive technology that uses high-intensity ultrasound waves to destroy tumours for liver cancer patients. The service will commence towards the end of March. Histotripsy was first introduced in Hong Kong...
Kelun-Biotech’s TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) Approved for Marketing in Second Indication by NMPA for EGFRm NSCLC
CHENGDU, China, March 10, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, formerly SKB264/MK-2870) was approved for marketing by the National Medical Products Administration (NMPA) for the second indication which is for the treatment of adult patients with epidermal growth factor receptor (EGFR) mutant-positive locally advanced...
Lundbeck’s potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan
VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA). H. Lundbeck A/S (Lundbeck) announced that amlenetug has received Orphan Drug Designation (ODD) from the MHLW in Japan.The ODD in Japan...
Free online course from Knowledge•Action•Change introduces new approaches in fight against smoking-related death and disease
LONDON, March 10, 2025 /PRNewswire/ -- UK-based public health agency, Knowledge•Action•Change (K•A•C), is launching a free online course called Understanding Tobacco Harm Reduction in a bid to reduce the disease and mortality caused by combustible tobacco and toxic smokeless products. A free online course called Understanding Tobacco Harm Reduction has been launched by Knowledge•Action•Change in a bid to reduce smoking-related...
